Sharing Best Practices for Successful Clinical Trials
A series written by The Michael J. Fox Foundation for Parkinson’s Research called Eye on Patient Advocacy, discusses how to increase the success of clinical research studies in areas like trial recruitment and retention.
Over a year ago, the staff of The Michael J. Fox Foundation for Parkinson’s Research (MJFF) began writing a series of articles, called Eye on Patient Advocacy. This series discusses how to increase the success of clinical research studies in areas like trial recruitment and retention using case studies from Parkinson's research. The six articles, on topics ranging from digital marketing to the importance of site selection, can be found compiled in a recent blog post by MJFF.
Read the blog post and series, here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
